Login to Your Account



Toucan Capital Brings Firm Back From Brink

Northwest Biotherapeutics' Cancer Effort Still Kicking

By Randall Osborne


Monday, February 7, 2005

When company officials from Northwest Biotherapeutics Inc. met with would-be financiers from Toucan Capital II LP at 2004's JPMorgan Healthcare Conference, NBI was "quite literally a week from closing its doors," recalled Alton Boynton, president, chief operating officer and co-founder of NBI.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription